RTI Biologics receives 510(k) clearance for porcine dermis Implant RTI Biologics has received 510(k) clearance from the FDA for its porcine dermis implant. The implant is intended for use in soft tissue repair procedures such as hernia repair. The implants will be processed at RTIís facility in Neunkirchen, Germany for commercial distribution in the U.S. later this year. The facility has begun production of the implants.
News For RTIX From The Last 14 Days
Check below for free stories on RTIX the last two weeks.